Bayer

Elanco to buy Bayer's animal health business for $7.6B, as dealmaking gathers steam in the sector
Elanco to buy Bayer's animal health business for $7.6B, as dealmaking gathers steam in the sector
Endpoints
Elanco
Bayer
M&A
animal health
Flag link:
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
Reuters
Roche
Rozlytrek
Bayer
Eli Lilly
personalized medicine
Flag link:
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work
Xconomy
Bayer
Versant Ventures
cell therapy
M&A
BlueRock Therapeutics
Flag link:
Bayer, Elanco could lock up animal health merger next week: report
Bayer, Elanco could lock up animal health merger next week: report
Fierce Pharma
Bayer
Elanco
M&A
animal health
Flag link:
Bayer's Prostate Cancer Drug Earns FDA Approval
Bayer's Prostate Cancer Drug Earns FDA Approval
BioSpace
Bayer
Nubeqa
darolutamide
prostate cancer
Flag link:
Bayer teams up with AI firm Sensyne Health to mine NHS data for its heart disease pipeline
Bayer teams up with AI firm Sensyne Health to mine NHS data for its heart disease pipeline
Fierce Biotech
Bayer
UK
Sensyne Health
artificial intelligence
cardiovascular disease
Flag link:
Bayer, Orion win speedy approval for prostate cancer drug darolutamide
Bayer, Orion win speedy approval for prostate cancer drug darolutamide
Endpoints
Bayer
Orion
prostate cancer
darolutamide
FDA
Flag link:
Roche, like Bayer, was hit in Winnti cyberattack
Roche, like Bayer, was hit in Winnti cyberattack
Fierce Pharma
Bayer
Roche
hacking
cyberattack
cybersecruity
Flag link:
Bayer recalls mislabeled vials of hemophilia A treatment
Bayer recalls mislabeled vials of hemophilia A treatment
Fierce Pharma
Bayer
product recalls
hemophilia A
Kogenate FS
Jivi
Flag link:
Bristol-Myers, Ono, Bayer Team Up for Colorectal Cancer Study
Bristol-Myers, Ono, Bayer Team Up for Colorectal Cancer Study
Yahoo/Zacks.com
Bristol-Myers Squibb
Bayer
Ono Pharmaceutical
Opdivo
Stivarga
metastatic colorectal cancer
Flag link:
Bayer, Bristol-Myers Squibb and Ono Pharma Team on Colorectal Cancer
Bayer, Bristol-Myers Squibb and Ono Pharma Team on Colorectal Cancer
BioSpace
Bayer
Bristol-Myers Squibb
Ono Pharmaceutical
metastatic colorectal cancer
Flag link:
Bayer-backed Pyxis debuts with $22M to pursue new immuno-oncology targets
Bayer-backed Pyxis debuts with $22M to pursue new immuno-oncology targets
BioCentury
Pyxis
Bayer
immuno-oncology
Flag link:
Bayer floats animal health merger with Lilly spinoff Elanco: report
Bayer floats animal health merger with Lilly spinoff Elanco: report
Fierce Pharma
Bayer
animal health
Elanco
Eli Lilly
M&A
Flag link:
Bayer/J&J eye new pediatric use for anticoagulant Xarelto
Bayer/J&J eye new pediatric use for anticoagulant Xarelto
Pharmaforum
Bayer
JNJ
Xarelton
pediatrics
Flag link:
Bayer powers Versant cell therapy startup to $250M round
Bayer powers Versant cell therapy startup to $250M round
Fierce Biotech
Versant Ventures
Century Therapeutics
cell therapy
Bayer
venture capital
Flag link:
Bristol-Myers star Opdivo fails survival test in a matchup with Nexavar aimed at shaking up the big HCC market
Bristol-Myers star Opdivo fails survival test in a matchup with Nexavar aimed at shaking up the big HCC market
Endpoints
Bristol-Myers Squibb
Opdivo
Bayer
Nexavar
liver cancer
clinical trials
Flag link:
Bayer begins phase 3 trial testing aflibercept in infant blindness
Bayer begins phase 3 trial testing aflibercept in infant blindness
Pharmaforum
Bayer
clinical trials
infant blindness
Aflibercept
retinopathy of prematurity
Flag link:
Bayer’s regorafenib kicks off brain cancer platform trial
Bayer’s regorafenib kicks off brain cancer platform trial
Pharmaforum
Bayer
brain cancer
clinical trials
GBM
regorafenib
Flag link:
FDA Received 6,000 Reports About Essure in 2018
FDA Received 6,000 Reports About Essure in 2018
Medical Devices and Diagnostics Industry
devices
FDA
Essure
Bayer
contraceptives
Flag link:
Bayer inks Arvinas deal to develop protein degraders
Bayer inks Arvinas deal to develop protein degraders
Fierce Biotech
Bayer
Arvinas
targeted protein degradation
Flag link:

Pages